These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35070429)

  • 1. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.
    Sun B; Ji WD; Wang WC; Chen L; Ma JY; Tang EJ; Lin MB; Zhang XF
    Front Genet; 2023; 14():1265866. PubMed ID: 38028589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circulating tumor cells undergoing EMT and short-term efficacy following interventional treatment in patients with hepatocellular carcinoma.
    Chen M; Xu R; Wu L; Chen X
    J Interv Med; 2020 Sep; 3(3):146-150. PubMed ID: 34805926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.
    Lei Y; Wang X; Tian Y; Xu R; Pei J; Fu Y; Sun H; Wang Y; Zheng P; Xia F; Wang J
    Front Med (Lausanne); 2023; 10():1209403. PubMed ID: 37841010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
    Bai T; Mai R; Ye J; Chen J; Qi L; Tang J; Wei M; Zhang L; Chen Z; Tang Z; Li L; Wu F
    Transl Cancer Res; 2020 Mar; 9(3):1384-1394. PubMed ID: 35117486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis.
    Yu JJ; Li YN; Shu C; Yang HY; Huang Z; Tao R; Chen YY; Chen XP; Xiao W
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8981-8991. PubMed ID: 37160624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
    Front Oncol; 2020; 10():1758. PubMed ID: 33224869
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
    Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
    Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Zhang Q; Xing W; Zhang J; Hu J; Qi L; Xiang B
    Onco Targets Ther; 2021; 14():1543-1552. PubMed ID: 33688202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
    Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
    Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
    Zhao L; Song J; Sun Y; Ju Q; Mu H; Dong X; Ding J; Liu Y; Wang X; Sun L; Wu J; Jiao Y; Lu S; Zhao X
    Cancer Med; 2023 Jul; 12(13):13912-13927. PubMed ID: 37337648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
    Front Oncol; 2021; 11():734564. PubMed ID: 34722281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.